These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17914066)

  • 1. Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals.
    Cole MA; Margolick JB; Cox C; Li X; Selnes OA; Martin EM; Becker JT; Aronow HA; Cohen B; Sacktor N; Miller EN;
    Neurology; 2007 Dec; 69(24):2213-20. PubMed ID: 17914066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable benefit in neuropsychological function in HIV-infected HAART-treated patients.
    Cysique LA; Maruff P; Brew BJ
    Neurology; 2006 May; 66(9):1447-50. PubMed ID: 16682686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged statin administration does not act on the cell-mediated immunity of HIV-infected dyslipidemic patients treated with a steady and effective highly active antiretroviral therapy. A two-year prospective study of statin versus fibrate administration.
    Manfredi R; Calza L; Chiodo F
    J Biol Regul Homeost Agents; 2006; 20(1-2):1-9. PubMed ID: 18088548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment.
    Roux P; Carrieri MP; Cohen J; Ravaux I; Poizot-Martin I; Dellamonica P; Spire B
    Clin Infect Dis; 2009 Nov; 49(9):1433-40. PubMed ID: 19807275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up.
    Gibbie T; Mijch A; Ellen S; Hoy J; Hutchison C; Wright E; Chua P; Judd F
    HIV Med; 2006 Mar; 7(2):112-21. PubMed ID: 16420256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus-associated prostate cancer: clinicopathological findings and outcome in a multi-institutional study.
    Pantanowitz L; Bohac G; Cooley TP; Aboulafia D; Dezube BJ
    BJU Int; 2008 Jun; 101(12):1519-23. PubMed ID: 18384640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.
    Wolbers M; Battegay M; Hirschel B; Furrer H; Cavassini M; Hasse B; Vernazza PL; Bernasconi E; Kaufmann G; Bucher HC;
    Antivir Ther; 2007; 12(6):889-97. PubMed ID: 17926643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Highly active antiretroviral therapy in HIV sero-positive children. Disease progression by baseline clinical, immunological and virological status].
    Rodríguez de Schiavi MS; Scrigni A; García Arrigoni P; Bologna R; Barboni G; Redondo J; Nastri M; Mecikovsky D; Cantisano C; Moreno R; Siciliani D; Lencina M; Luedicke N; Rezzónico G; Torolla JL; López Papucci S; Luis M; Libonati C; Gamba L; Barbarysky J; Pérez Hernández E; Zlatkes R
    Arch Argent Pediatr; 2009 Jun; 107(3):212-20. PubMed ID: 19543629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of antiretroviral therapy on viral tropism in HIV-infected patients followed longitudinally for over 5 years.
    Briz V; Poveda E; del Mar González M; Martín-Carbonero L; González-González R; Soriano V
    J Antimicrob Chemother; 2008 Feb; 61(2):405-10. PubMed ID: 18063598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era.
    Chiao EY; Giordano TP; Richardson P; El-Serag HB
    J Clin Oncol; 2008 Jan; 26(3):474-9. PubMed ID: 18202423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reaction time in patients with HIV/AIDS and correlation with CD4 count: a case-control study.
    Ogunrin AO; Odiase FE; Ogunniyi A
    Trans R Soc Trop Med Hyg; 2007 May; 101(5):517-22. PubMed ID: 17254620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy.
    Golub ET; Benning L; Sharma A; Gandhi M; Cohen MH; Young M; Gange SJ
    Clin Infect Dis; 2008 Jan; 46(2):305-12. PubMed ID: 18171267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
    Lima VD; Harrigan R; Murray M; Moore DM; Wood E; Hogg RS; Montaner JS
    AIDS; 2008 Nov; 22(17):2371-80. PubMed ID: 18981777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
    Isgrò A; Leti W; De Santis W; Marziali M; Esposito A; Fimiani C; Luzi G; Pinti M; Cossarizza A; Aiuti F; Mezzaroma I
    Clin Infect Dis; 2008 Jun; 46(12):1902-10. PubMed ID: 18462177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 infected patients older than 50 years. PISCIS cohort study.
    Navarro G; Nogueras MM; Segura F; Casabona J; Miro JM; Murillas J; Tural C; Ferrer E; Jaén A; Force L; Vilaró J; García I; Masabeu A; Altés J; Esteve A; Sued O; Riera M; Clotet B; Podzamczer D; Gatell JM;
    J Infect; 2008 Jul; 57(1):64-71. PubMed ID: 18572247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy.
    Skinner S; Adewale AJ; DeBlock L; Gill MJ; Power C
    HIV Med; 2009 Apr; 10(4):246-52. PubMed ID: 19187172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
    Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N
    HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.